Cargando…
Targeting hypoxic response for cancer therapy
Hypoxic tumor microenvironment (HTM) is considered to promote metabolic changes, oncogene activation and epithelial mesenchymal transition, and resistance to chemo- and radio-therapy, all of which are hallmarks of aggressive tumor behavior. Cancer cells within the HTM acquire phenotypic properties t...
Autores principales: | Paolicchi, Elisa, Gemignani, Federica, Krstic-Demonacos, Marija, Dedhar, Shoukat, Mutti, Luciano, Landi, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924654/ https://www.ncbi.nlm.nih.gov/pubmed/26859576 http://dx.doi.org/10.18632/oncotarget.7229 |
Ejemplares similares
-
Targeting hypoxic tumour cells to overcome metastasis
por: Bennewith, Kevin L, et al.
Publicado: (2011) -
Insight into glucocorticoid receptor signalling through interactome model analysis
por: Bakker, Emyr, et al.
Publicado: (2017) -
BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment
por: Guazzelli, Alice, et al.
Publicado: (2019) -
Protein disulfide isomerase A1 regulates breast cancer cell immunorecognition in a manner dependent on redox state
por: Alhammad, Rashed, et al.
Publicado: (2020) -
Interplay of Carbonic Anhydrase IX With Amino Acid and Acid/Base Transporters in the Hypoxic Tumor Microenvironment
por: Venkateswaran, Geetha, et al.
Publicado: (2020)